Overview

Update
Total Equity Funding
$1.63M in 1 Round
Most Recent Funding
$1.63 Million on June 11, 2011 / Undisclosed Round
Headquarters:
Cambridge
Description:
Phico Therapeutics is developing a unique antibiotic technology to destroy multi-drug resistant bacteria in the human anatomy.
Categories:
Biotechnology
Website:
http://www.phicotherapeutics.co.uk

Company Details

Update

Phico Therapeutics is developing a unique antibiotic technology to address one the most urgent challenges facing medicine today – how to destroy multi-drug resistant bacteria, the so-called “superbugs”.

Phico’s patented platform utilises an antibacterial protein, SASP to inactivate bacterial DNA and cause rapid destruction of target bacteria. SASPject™ is a new class of antibiotic which could provide many advantages over conventional antibiotic classes.

Funding Rounds (1) - $1.63M

Update
DateAmount / RoundValuationLead InvestorInvestors
Jun, 2011£1M / Undisclosed0

News (1)

Update
DateNews
Apr 28, 2010businessweekly.co.uk - Phico Therapeutics raises 1630571 in unknown round

Offices/Locations (1)

Update
  • Office

    Babraham Research Campus

    Babraham

    Cambridge, CB22 3AT

    GBR

Images (1)

Update

Add Acquisitions

Add Current Team

Add Board Members and Advisors

Add Products

Add Sub Organizations

Add Competitors

Add Memberships

Add Customers

Add Partners

Add Videos